Alkem Laboratories has launched a new product called Renocia cyclical therapy kit, a weekly nutritional supplementation regimen designed to support hair growth, strengthen hair follicles, and manage hair loss. The kit contains a set of vegetarian-sourced supplements, including vitamins, minerals, and amino acids, which are taken on specific days of the week. This structured protocol allows for better nutrient absorption and utilization.<\/p>\n
According to Dr. Vikas Gupta, CEO of Alkem, nutritional supplementation plays a crucial role in hair health, but outcomes can vary depending on nutrient selection, absorption, and long-term adherence. The Renocia cyclical therapy kit offers a targeted approach that aligns with the body’s natural nutritional requirements throughout the week. By using only vegetarian-sourced ingredients, the company aims to make the product accessible to all sections of the Indian population.<\/p>\n
The kit is available in a convenient wallet pack that contains supplements for four weeks, with clear instructions on which tablets to take on each day. The product is formulated separately for men and women to cater to their specific nutritional needs. Renocia cyclical therapy is a prescription product, and Alkem has a growing portfolio of products in the dermatology segment, including skin and hair care products.<\/p>\n
The Renocia brand offers a range of hair care products, including hair revitalizing shampoo, conditioner, serum, and oral supplements. The launch of the cyclical therapy kit is a significant addition to the brand’s portfolio, providing a comprehensive solution for hair care. With its scientifically-designed regimen and vegetarian-sourced ingredients, the Renocia cyclical therapy kit is poised to make a positive impact on the hair care market in India.<\/p>\n
Overall, the Renocia cyclical therapy kit is a innovative product that offers a structured approach to hair care, providing a convenient and effective solution for individuals looking to support hair growth and manage hair loss. With its focus on vegetarian-sourced ingredients and separate formulations for men and women, the product is likely to appeal to a wide range of consumers in India.<\/p>\n","protected":false},"excerpt":{"rendered":"
Alkem Laboratories has launched a new product called Renocia cyclical therapy kit, a weekly nutritional supplementation regimen designed to support hair growth, strengthen hair follicles, and manage hair loss. The kit contains a set of vegetarian-sourced supplements, including vitamins, minerals, and amino acids, which are taken on specific days of the week. This structured protocol […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","fifu_image_url":"","fifu_image_alt":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[22,2],"tags":[],"class_list":["post-89787","post","type-post","status-publish","format-standard","hentry","category-alkem","category-pharma"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":89838,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/22\/alkem-laboratories-slapped-with-%e2%82%b92-35-crore-gst-demand-notice-and-penalty-by-additional-commissioner-as-reported-by-scanx-trade\/","url_meta":{"origin":89787,"position":0},"title":"Alkem Laboratories slapped with \u20b92.35 crore GST demand notice and penalty by Additional Commissioner, as reported by scanx.trade","author":"Team Small News","date":"January 22, 2026","format":false,"excerpt":"Alkem Laboratories, a prominent Indian pharmaceutical company, has received a Goods and Services Tax (GST) demand order from the Additional Commissioner, totaling \u20b92.35 crore, along with a penalty. The order, which was issued on [date], has sparked concerns among the company's stakeholders and has the potential to impact its financial\u2026","rel":"","context":"In "Alkem"","block_context":{"text":"Alkem","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/alkem\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89849,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/24\/delhi-high-court-dismisses-alkems-bid-to-trademark-a-to-z\/","url_meta":{"origin":89787,"position":1},"title":"Delhi High Court Dismisses Alkem’s Bid to Trademark ‘A TO Z’","author":"Team Small News","date":"January 24, 2026","format":false,"excerpt":"The Delhi High Court has rejected a trademark claim by Alkem Laboratories, a pharmaceutical company, over the use of the term \"A TO Z\" for its products. The court ruled that alphabets are public property and cannot be monopolized by a single entity. Alkem Laboratories had filed a lawsuit against\u2026","rel":"","context":"In "Alkem"","block_context":{"text":"Alkem","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/alkem\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89830,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/21\/cipla-collaborates-with-immunoact-to-introduce-car-t-cell-therapy-for-blood-cancer-treatment-in-african-markets\/","url_meta":{"origin":89787,"position":2},"title":"Cipla Collaborates with ImmunoACT to Introduce CAR-T Cell Therapy for Blood Cancer Treatment in African Markets.","author":"Team Small News","date":"January 21, 2026","format":false,"excerpt":"Cipla, a leading pharmaceutical company, has partnered with ImmunoACT, a biotech firm, to launch CAR-T cell therapy for the treatment of blood cancers in Africa. This collaboration aims to make this innovative and potentially life-saving treatment more accessible to patients in the region. CAR-T cell therapy is a form of\u2026","rel":"","context":"In "Cipla"","block_context":{"text":"Cipla","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/cipla\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89668,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2025\/12\/14\/renowned-physician-dr-apollo-discloses-the-ideal-cooking-oil-for-individuals-struggling-with-excess-weight-and-elevated-cholesterol-levels\/","url_meta":{"origin":89787,"position":3},"title":"Renowned physician, Dr. Apollo, discloses the ideal cooking oil for individuals struggling with excess weight and elevated cholesterol levels.","author":"Team Small News","date":"December 14, 2025","format":false,"excerpt":"The quality of cooking oil used in daily meals plays a significant role in maintaining overall health, particularly heart wellness and cholesterol balance. Dr. Sudhir Kumar, a senior doctor at Apollo Hospitals, Hyderabad, recently shared insights on the benefits of using rice bran oil over sunflower oil in Indian kitchens.\u2026","rel":"","context":"In "Apollo Hospital"","block_context":{"text":"Apollo Hospital","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/apollo-hospital\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89869,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/27\/zydus-lifesciences-introduces-indias-first-biosimilar-version-of-nivolumab-a-global-breakthrough\/","url_meta":{"origin":89787,"position":4},"title":"Zydus Lifesciences introduces India’s first biosimilar version of Nivolumab, a global breakthrough.","author":"Team Small News","date":"January 27, 2026","format":false,"excerpt":"Zydus Lifesciences, a leading life sciences company, has launched the world's first biosimilar of nivolumab in India under the brand name Tishtha. This milestone marks a significant expansion of patient access to cutting-edge cancer therapies, particularly in the field of Immuno-Oncology. Tishtha will be available in two dosage strengths, 100\u2026","rel":"","context":"In "Pharma"","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Zydus-Logo.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Zydus-Logo.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Zydus-Logo.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Zydus-Logo.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":89683,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2025\/12\/19\/zydus-lifesciences-partners-to-introduce-diagnostic-tests-for-cancer-risk-evaluation-in-indian-market\/","url_meta":{"origin":89787,"position":5},"title":"Zydus Lifesciences Partners to Introduce Diagnostic Tests for Cancer Risk Evaluation in Indian Market","author":"Team Small News","date":"December 19, 2025","format":false,"excerpt":"Zydus Lifesciences Limited is a global life sciences company based in India that is involved in the discovery, development, manufacture, and marketing of a wide range of healthcare therapies. The company operates in the business of integrated pharmaceutical operations, offering a diverse product portfolio that includes active pharmaceutical ingredients (API),\u2026","rel":"","context":"In "Pharma"","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Zydus-Logo.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Zydus-Logo.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Zydus-Logo.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Zydus-Logo.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]}],"_links":{"self":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts\/89787","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/comments?post=89787"}],"version-history":[{"count":0,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts\/89787\/revisions"}],"wp:attachment":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/media?parent=89787"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/categories?post=89787"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/tags?post=89787"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}